JPMorgan Chase & Co. downgraded shares of Basf (OTCMKTS:BASFY) from an overweight rating to a neutral rating in a report released on Monday, MarketBeat.com reports.
Several other research analysts also recently commented on the company. UBS Group downgraded Basf from a buy rating to a neutral rating in a research report on Thursday, December 7th. Zacks Investment Research downgraded Basf from a hold rating to a sell rating in a research report on Monday, October 16th. Berenberg Bank raised Basf from a hold rating to a buy rating in a research report on Wednesday, November 22nd. ValuEngine downgraded Basf from a buy rating to a hold rating in a research report on Wednesday, October 18th. Finally, Goldman Sachs Group raised Basf from a sell rating to a neutral rating in a research report on Thursday, September 28th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $31.00.
Shares of Basf (BASFY) traded down $0.19 during midday trading on Monday, reaching $28.34. The company’s stock had a trading volume of 133,455 shares, compared to its average volume of 150,357. The company has a current ratio of 1.99, a quick ratio of 1.29 and a debt-to-equity ratio of 0.43. The company has a market cap of $104,400.00, a P/E ratio of 65.91, a P/E/G ratio of 1.77 and a beta of 1.11. Basf has a 52 week low of $22.98 and a 52 week high of $28.69.
BASF SE is a chemical company. The Company operates through five segments, which include Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions, and Oil & Gas. The Chemicals segment consists of the Petrochemicals, Monomers and Intermediates divisions. The Performance Products segment consists of the Dispersions & Pigments, Care Chemicals, Nutrition & Health, and Performance Chemicals divisions.
What are top analysts saying about Basf? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Basf and related companies.